NCT05041322View on ClinicalTrials.gov

Improving Ventilatory Capacity in Those With Chronic High Level SCI

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 29, 2020

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Spinal Cord Injuries
Interventions
DRUG

Buspirone

Subjects take 30 mg buspirone HCl (15 mg twice a day) for 14 Days.

DRUG

Placebo

Subjects take placebo pills (twice a day) for 14 Days.

Trial Locations (1)

02138

Spaulding Hospital Cambridge, Cambridge

All Listed Sponsors
lead

Spaulding Rehabilitation Hospital

OTHER

NCT05041322 - Improving Ventilatory Capacity in Those With Chronic High Level SCI | Biotech Hunter | Biotech Hunter